Activation of GSK3β/β-TrCP axis via PHLPP1 exacerbates Nrf2 degradation leading to impairment in cell survival pathway during diabetic nephropathy

This publication has 33 references indexed in Scilit:

• The regulation of cellular metabolism by tumor suppressor p53
  Cell & Bioscience, 2013
• Glucose availability is a decisive factor for Nrf2-mediated gene expression
  Redox Biology, 2013
• Structural and Functional Characterization of Nrf2 Degradation by the Glycogen Synthase Kinase 3/β-TrCP Axis
  Molecular and Cellular Biology, 2012
• Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
  Diabetes Care, 2012
• Nrf2 Activators as Attractive Therapeutics for Diabetic Nephropathy
  Diabetes, 2011
• SCF/β-TrCP Promotes Glycogen Synthase Kinase 3-Dependent Degradation of the Nrf2 Transcription Factor in a Keap1-Independent Manner
  Molecular and Cellular Biology, 2011
• Transcription factor Nrf2 maintains the basal expression of Mdm2: An implication of the regulation of p53 signaling by Nrf2
  Archives of Biochemistry and Biophysics, 2011
• β-TrCP-Mediated Ubiquitination and Degradation of PHLPP1 Are Negatively Regulated by Akt
  Molecular and Cellular Biology, 2009
• Bacopa monnieri modulates antioxidant responses in brain and kidney of diabetic rats
  Environmental Toxicology and Pharmacology, 2009
• The Nuclear Ubiquitin-Proteasome System Degrades MyoD
  Journal of Biological Chemistry, 2001